The role of glutathione peroxidase 4 in the progression, drug resistance, and targeted therapy of non-small cell lung cancer

JIAHENG WEI¹, LIANGMING ZHU^2,*
1 School of Clinical Medicine, Shandong Second Medical University, Weifang, 261000, China
2 Department of Thoracic Surgery, Jinan Central Hospital, Shandong University, Jinan, 250000, China
* Corresponding Author: LIANGMING ZHU. Email: email

Oncology Research https://doi.org/10.32604/or.2024.054201

Received 21 May 2024; Accepted 26 August 2024; Published online 23 September 2024

Download PDF

Abstract

Lung cancer is one of the main causes of cancer-related deaths globally, with non-small cell lung cancer (NSCLC) being the most prevalent histological subtype of lung cancer. Glutathione peroxidase 4 (GPX4) is a crucial antioxidant enzyme that plays a role in regulating ferroptosis. It is also involved in a wide variety of biological processes, such as tumor cell growth invasion, migration, and resistance to drugs. This study comprehensively examined the role of GPX4 in NSCLC and investigated the clinical feasibility of targeting GPX4 for NSCLC treatment. We discovered that GPX4 influences the progression of NSCLC by modulating multiple signaling pathways, and that blocking GPX4 can trigger ferroptosis and increase the sensitivity to chemotherapy. As a result, GPX4 represents a prospective therapeutic target for NSCLC. Targeting GPX4 inhibits the development of NSCLC cells and decreases their resistance to treatment.

Keywords

Non-small cell lung cancer (NSCLC); Glutathione peroxidase 4 (GPX4); Drug resistance; Inhibitor; Biological function

Downloads
- Full-Text PDF
Citation Tools
- BibTex
- EndNote
- RIS

169

View
25

Download
0

Like

STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma
Kazuhiro Yamamoto, Takeshi Ioroi,...
Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer
Shuai Liu, Lu Lu, Feng Pan, Chunsheng...
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations
Yudie Yang, Xia Zhang, Yajie Gao,...
VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling
Xiangbin Tan, Zefei Liao, Shuangyou...
miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
Xiao-Na Li, Hong Yang, Tao Yang

All issues

Online First

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

Past Issues

The role of glutathione peroxidase 4 in the progression, drug resistance, and targeted therapy of non-small cell lung cancer

Abstract

Keywords

169

25

0

Further Information

Guidelines

Follow Us

Join Us

Contact Us

WhatsApp:

Share Link